Dr. Cynthia Ma on the METRIC Trial in Triple-Negative Breast Cancer

2021 ASCO Direct St. Louis | Early Stage Breast Cancer Summary | Dr. Cynthia MaПодробнее

Radiation Therapy Based on LUMINA Trial | Cynthia Ma, MD, PhD | ASCO22 Breast Cancer UpdatesПодробнее

Cynthia Ma, MD | Key Takeaways on Breast Cancer at 2019 ASCO Direct Highlights St. LouisПодробнее

The importance of a biomarker-directed approach in triple-negative breast cancerПодробнее

Metastatic Triple-Negative Breast Cancer Ongoing TrialsПодробнее

Cynthia Ma, MD | Advice on Breast Cancer at 2019 ASCO Direct Highlights St. LouisПодробнее

CARG Score Chemotherapy Options ABCSG 18 Trial | Cynthia Ma, MD, PhD | ASCO22 Breast Cancer UpdatesПодробнее

Dr. Cynthia Ma on Immunotherapy in TNBCПодробнее

Dr. Cynthia Ma- Pedal the CauseПодробнее

Testing and Targeted Therapy in Triple Negative Breast Cancer: 2023 West OncologyПодробнее

New Frontiers in Triple Negative Breast CancerПодробнее

TNBC in Black WomenПодробнее

TNT Study in Triple Negative Breast CancerПодробнее

Monday Morning Medical Update: Cynthia Newsome’s Cancer JourneyПодробнее

AR+ Triple Negative Breast Cancer Clinical TrialПодробнее

Morning Medical Update Episode 284 Tuesday 10-3-23 - Cynthia NewsomeПодробнее

Breast Cancer Trials Q&A: Triple Negative Breast CancerПодробнее

Issues in Triple Negative Breast Cancer: 2023 Best of Breast ConferenceПодробнее

Dr Ma on Questions Regarding Treatment Sequencing in CDK4/6 Inhibitor–Resistant Breast CancerПодробнее